Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/272
Title: Comparative study of clinical efficacy of tolperisone vs baclofen in treating spasticity in children with cerebral palsy: a one year randomized controlled trial
Authors: Dr.Deepthi S.M, BM0118001
Keywords: Spastic cerebral palsy, Spasticity, Baclofen and Tolperisone
Issue Date: 2021
Publisher: K.L.E. Academy of Higher Education & Research, Belagavi
Abstract: INTRODUCTION: Spastic cerebral palsy is the most common type and its medical management with baclofen has many side effects. Hence there is need for other drugs in management of spastic cerebral palsy. Tolperisone which is centrally acting drug has been shown to reduce spasticity in adults. However there are not much studies on use of tolperisone in children with spastic cerebral palsy.
URI: http://localhost:8080/xmlui/handle/123456789/272
Appears in Collections:Pediatrics MD

Files in This Item:
File Description SizeFormat 
BM0118001 Dr.Deepthi S.M.pdf3.41 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.